NO20063171L - Endoparasitisidale sammensetninger for topisk anvendelse - Google Patents

Endoparasitisidale sammensetninger for topisk anvendelse

Info

Publication number
NO20063171L
NO20063171L NO20063171A NO20063171A NO20063171L NO 20063171 L NO20063171 L NO 20063171L NO 20063171 A NO20063171 A NO 20063171A NO 20063171 A NO20063171 A NO 20063171A NO 20063171 L NO20063171 L NO 20063171L
Authority
NO
Norway
Prior art keywords
endoparasitic
compositions
topical application
endoparasites
praziquantel
Prior art date
Application number
NO20063171A
Other languages
English (en)
Norwegian (no)
Inventor
Hans-Juergen Hamann
Venkata-Rangarao Kanikanti
Michael Traubel
Thomas Bach
Gertraut Altreuther
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of NO20063171L publication Critical patent/NO20063171L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20063171A 2003-12-13 2006-07-07 Endoparasitisidale sammensetninger for topisk anvendelse NO20063171L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10358525A DE10358525A1 (de) 2003-12-13 2003-12-13 Endoparasitizide Mittel zur topischen Applikation
PCT/EP2004/013552 WO2005055973A2 (de) 2003-12-13 2004-11-30 Endoparasitizide mittel zur topischen applikation

Publications (1)

Publication Number Publication Date
NO20063171L true NO20063171L (no) 2006-07-07

Family

ID=34638681

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063171A NO20063171L (no) 2003-12-13 2006-07-07 Endoparasitisidale sammensetninger for topisk anvendelse

Country Status (31)

Country Link
US (1) US7763583B2 (https=)
EP (1) EP1694291B1 (https=)
JP (1) JP4842141B2 (https=)
KR (1) KR101272139B1 (https=)
CN (1) CN1893919B (https=)
AR (1) AR046878A1 (https=)
AT (1) ATE447940T1 (https=)
AU (1) AU2004296537B2 (https=)
BR (1) BRPI0417578B1 (https=)
CA (1) CA2548897C (https=)
CR (1) CR8428A (https=)
DE (2) DE10358525A1 (https=)
DK (1) DK1694291T3 (https=)
ES (1) ES2334920T3 (https=)
GT (1) GT200400264A (https=)
HR (1) HRP20100056T1 (https=)
IL (1) IL176151A (https=)
MX (1) MXPA06006594A (https=)
MY (1) MY142044A (https=)
NO (1) NO20063171L (https=)
NZ (1) NZ547837A (https=)
PE (1) PE20050919A1 (https=)
PL (1) PL1694291T3 (https=)
PT (1) PT1694291E (https=)
RU (1) RU2401108C2 (https=)
SI (1) SI1694291T1 (https=)
TW (1) TWI341202B (https=)
UA (1) UA85574C2 (https=)
UY (1) UY28662A1 (https=)
WO (1) WO2005055973A2 (https=)
ZA (1) ZA200604744B (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
US8119159B2 (en) 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
US20070148228A1 (en) * 1999-02-22 2007-06-28 Merrion Research I Limited Solid oral dosage form containing an enhancer
DE102004055316A1 (de) * 2004-11-16 2006-05-18 Bayer Healthcare Ag Verhinderung vertikaler Endoparasiten-Infektionen
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
KR101191322B1 (ko) 2006-04-07 2012-10-16 메리온 리서치 Ⅲ 리미티드 증진제를 함유하는 고형 경구용 투여 제형
EP2040731A4 (en) * 2006-06-09 2010-05-19 Merrion Res Iii Ltd SOLID DOSAGE FORM FOR ORAL ADMINISTRATION CONTAINING AN ACTIVATOR
PE20081406A1 (es) * 2006-12-20 2008-10-17 Schering Plough Ltd Composiciones farmaceuticas de flunixina
CN107096012A (zh) * 2008-05-07 2017-08-29 诺和诺德股份有限公司 肽的组合物及其制备方法
DE102008022520A1 (de) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
ES2617672T3 (es) * 2008-10-08 2017-06-19 Zoetis Services Llc Composiciones antihelmínticas de bencimidazol
US20100215743A1 (en) * 2009-02-25 2010-08-26 Leonard Thomas W Composition and drug delivery of bisphosphonates
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
AP2909A (en) 2009-03-17 2014-05-31 Concert Pharmaceuticals Inc Pyrazinoisoquinoline Compounds
GB2472327B (en) 2009-07-31 2013-03-13 Shin Nippon Biomedical Lab Ltd Intranasal granisetron and nasal applicator
US20110182985A1 (en) * 2010-01-28 2011-07-28 Coughlan David C Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
WO2011120033A1 (en) 2010-03-26 2011-09-29 Merrion Research Iii Limited Pharmaceutical compositions of selective factor xa inhibitors for oral administration
EP2661273A4 (en) 2011-01-07 2014-06-04 Merrion Res Iii Ltd IRON PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION
US8680054B2 (en) * 2011-04-20 2014-03-25 Novartis Ag Suspension type topical formulations comprising cyclic depsipeptide
CN102283843A (zh) * 2011-06-29 2011-12-21 梁晓天 一种吡喹酮外用制剂及其制备方法和应用
AU2012357848C1 (en) * 2011-12-21 2018-07-19 Bayer Pharma Aktiengesellschaft Preparations containing amorphous emodepside
WO2014098619A1 (en) * 2012-12-18 2014-06-26 Donaghys Industries Limited Transdermal parasiticidal formulations
WO2015123480A2 (en) * 2014-02-14 2015-08-20 Dsm Ip Assets B.V. Compositions and methods for the prevention and/or treatment of schistosomiasis
US10265384B2 (en) 2015-01-29 2019-04-23 Novo Nordisk A/S Tablets comprising GLP-1 agonist and enteric coating
LT3298027T (lt) 2015-05-20 2021-08-10 Boehringer Ingelheim Animal Health USA Inc. Antihelmintiniai depsipeptido junginiai
RU2715556C2 (ru) 2015-12-28 2020-03-02 Мериал, Инк. Противогельминтные депсипептидные соединения
CA3044038A1 (en) 2016-11-16 2018-05-24 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
EP3480195A1 (en) 2017-11-07 2019-05-08 Bayer Animal Health GmbH Method for the synthesis of cyclic depsipeptides
PL3676265T3 (pl) 2017-11-07 2025-12-15 Elanco Animal Health Gmbh Sposób syntezy cyklicznych depsypeptydów
CN111346046B (zh) * 2020-03-06 2021-07-09 安徽农业大学 一种含莫西菌素注射用缓释凝胶制剂及制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US281292A (en) * 1883-07-17 onslow
DE2362539C2 (de) * 1973-12-17 1986-05-07 Merck Patent Gmbh, 6100 Darmstadt 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3619030A1 (de) * 1986-06-06 1987-12-10 Bayer Ag Topisch anwendbare zubereitungen
DE3634755A1 (de) 1986-10-11 1988-04-14 Bayer Ag Dermale behandlung von wurmerkrankungen der katze mit praziquantel
NO176766C (no) 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
US5874479A (en) * 1991-03-01 1999-02-23 Warner-Lambert Company Therapeutic permeation enhanced-wound healing compositions and methods for preparing and using same
DE4317458A1 (de) 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
DE4317432A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317457A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
NZ260018A (en) 1994-03-03 1995-10-26 Bomac Lab Ltd Benzimidazole compositions and anthelmintic compositions
DE19520275A1 (de) * 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
US5780487A (en) 1995-08-07 1998-07-14 Amer Moh Samir S-2'- 2-(1-methyl-2-piperidyl) ethyl! cinnamanilide
DE19601263A1 (de) 1996-01-16 1997-07-17 Bayer Ag Anthelmintische Paste
DE19628776A1 (de) 1996-07-17 1998-01-22 Bayer Ag Oral applizierbare Granulate von Hexahydropyrazinderivaten
US5837289A (en) * 1996-07-23 1998-11-17 Grasela; John C. Transdermal delivery of medications using a combination of penetration enhancers
DE19921887A1 (de) * 1999-05-12 2000-11-16 Bayer Ag Endoparasitizide Mittel
DE19941024A1 (de) 1999-08-28 2001-03-01 Hartmut Klocke Wirkstoffpräparat für tierärztliche Applikation und Verfahren zu seiner Herstellung
NZ518376A (en) * 1999-11-18 2004-01-30 Novartis Ag Pesticidal aminoheterocyclamide compounds
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
DE10008128A1 (de) 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
ATE320812T1 (de) 2000-10-10 2006-04-15 Wyeth Corp Anthelmintika
TWI292712B (en) * 2000-12-20 2008-01-21 Novartis Ag Aminoacetonitrile compounds for use in the control of endoparasites
GB0108485D0 (en) 2001-04-04 2001-05-23 Pfizer Ltd Combination therapy
US6893652B2 (en) 2001-08-27 2005-05-17 Wyeth Endoparasiticidal gel composition
PT1610613T (pt) * 2003-04-04 2017-03-07 Merial Inc Formulações veterinárias anti-helmínticas tópicas

Also Published As

Publication number Publication date
UY28662A1 (es) 2005-07-29
GT200400264A (es) 2005-08-18
BRPI0417578B1 (pt) 2015-12-22
EP1694291A2 (de) 2006-08-30
CA2548897C (en) 2012-04-10
RU2006124964A (ru) 2008-01-20
EP1694291B1 (de) 2009-11-11
PE20050919A1 (es) 2005-12-16
HK1102915A1 (en) 2007-12-07
AU2004296537A1 (en) 2005-06-23
AR046878A1 (es) 2005-12-28
CN1893919B (zh) 2010-09-29
TW200533384A (en) 2005-10-16
WO2005055973A2 (de) 2005-06-23
KR101272139B1 (ko) 2013-06-10
TWI341202B (en) 2011-05-01
IL176151A0 (en) 2006-10-05
ATE447940T1 (de) 2009-11-15
DK1694291T3 (da) 2010-03-15
ES2334920T3 (es) 2010-03-17
IL176151A (en) 2013-12-31
PT1694291E (pt) 2010-01-18
US20070060509A1 (en) 2007-03-15
NZ547837A (en) 2010-02-26
JP2007513903A (ja) 2007-05-31
KR20060103953A (ko) 2006-10-04
JP4842141B2 (ja) 2011-12-21
UA85574C2 (uk) 2009-02-10
WO2005055973A3 (de) 2005-08-11
HRP20100056T1 (hr) 2010-03-31
DE502004010367D1 (de) 2009-12-24
ZA200604744B (en) 2007-09-26
DE10358525A1 (de) 2005-07-07
PL1694291T3 (pl) 2010-04-30
AU2004296537B2 (en) 2010-05-13
SI1694291T1 (sl) 2010-03-31
CN1893919A (zh) 2007-01-10
CR8428A (es) 2006-11-23
MXPA06006594A (es) 2006-08-23
MY142044A (en) 2010-08-30
CA2548897A1 (en) 2005-06-23
BRPI0417578A (pt) 2007-03-20
US7763583B2 (en) 2010-07-27
RU2401108C2 (ru) 2010-10-10

Similar Documents

Publication Publication Date Title
NO20063171L (no) Endoparasitisidale sammensetninger for topisk anvendelse
NO20064584L (no) Tetrahydropyridoindolderivater
NO20064347L (no) Substituerte 1,2,3,4-tetrahydroisokinolinderivater
NO20072322L (no) Laktamforbindelser og anvendelse derav som farmasoytiske midler
NO20070372L (no) Amidoforbindelser og anvendelse derav som farmasoytiske preparater
NO20073059L (no) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
NO20073068L (no) Stereoisomere anrikete 3-aminokarbonylbisykloheptenpyrimidindiaminforindelser og deres anvendelse
NO20051941L (no) Kombinasjonskjemoterapisammensetninger og fremgangsmater.
SI1259218T1 (sl) Kozmetični sestavek za tretiranje starajoče se in ali obremenjene kože
EA200602062A1 (ru) Амидосоединения и их применение в качестве фармацевтических средств
NO20070487L (no) 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer.
NO20071048L (no) Amidoforbindelser og deres anvendelse som farmasoytika
NO20080068L (no) Topisk unguale formuleringer
NO20051102L (no) Sulfonylamino-eddiksyre-derivater
BRPI0514444A (pt) análogos de ciclopamina e métodos de uso destes
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
NO20075849L (no) Fremgangsmater og preparater til behandling eller forebygging av kreft
NO20050932L (no) 1-pyridin-4-yl-ureaderivater
ATE448777T1 (de) Mittel für die transdermale verabreichung von nikotin
NO20092073L (no) Modulatorer av C3A-reseptor, og fremgangsmater for anvendelse derav
NO20072290L (no) Organiske forbindelser.
CL2008002082A1 (es) Compuestos derivados de 6-fenil-1h-imidazo[4,5-c]piridina-4-carbonitrilo, inhibidores de catepsina s y catepsina k; composicion farmaceutica; y uso en el tratamiento de osteoporosis, aterosclerosis, inflamacion, entre otras enfermedades.
MX2007006539A (es) Sistema para la absorcion percutanea mejorada de los agentes beneficiadores de la piel.
DK1962815T3 (da) Anvendelse af filmdannende hårplejepolymerer fra gruppen polyurethaner og farmaceutiske tilberedninger og plastre indeholdende nævnte polymerer
BRPI0617294B8 (pt) composição farmacêutica em gel hidroalcóolico e uso de testosterona

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application